0001225208-20-003299.txt : 20200224
0001225208-20-003299.hdr.sgml : 20200224
20200224171504
ACCESSION NUMBER: 0001225208-20-003299
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200221
FILED AS OF DATE: 20200224
DATE AS OF CHANGE: 20200224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scanlon Meghan
CENTRAL INDEX KEY: 0001801586
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 20645481
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2020-02-21
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001801586
Scanlon Meghan
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
SVP,Pres,Urology Pelvic Health
Common Stock
2020-02-21
4
M
0
778.0000
0.0000
A
8099.0000
D
Common Stock
2020-02-21
4
F
0
264.0000
42.6200
D
7835.0000
D
Common Stock
2020-02-22
4
M
0
1159.0000
0.0000
A
8994.0000
D
Common Stock
2020-02-22
4
F
0
331.0000
42.6200
D
8663.0000
D
Common Stock
2020-02-23
4
M
0
1227.0000
0.0000
A
9890.0000
D
Common Stock
2020-02-23
4
F
0
359.0000
42.6200
D
9531.0000
D
Deferred Stock Units
2020-02-21
4
M
0
778.0000
0.0000
D
2023-02-21
Common Stock
778.0000
2337.0000
D
Deferred Stock Units
2020-02-22
4
M
0
1159.0000
0.0000
D
2021-02-22
Common Stock
1159.0000
1159.0000
D
Deferred Stock Units
2020-02-23
4
M
0
1227.0000
0.0000
D
2020-02-23
Common Stock
1227.0000
0.0000
D
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
/s/ Scott G. Hodgdon, Attorney-in-Fact
2020-02-24